SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-21-054629
Filing Date
2021-02-24
Accepted
2021-02-24 16:11:14
Documents
96
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d63231d10k.htm   iXBRL 10-K 2802990
2 EX-10.2 d63231dex102.htm EX-10.2 213309
3 EX-10.7 d63231dex107.htm EX-10.7 28063
4 EX-10.8 d63231dex108.htm EX-10.8 118824
5 EX-10.12 d63231dex1012.htm EX-10.12 35025
6 EX-10.16 d63231dex1016.htm EX-10.16 18474
7 EX-21.1 d63231dex211.htm EX-21.1 647
8 EX-23.1 d63231dex231.htm EX-23.1 3153
9 EX-31.1 d63231dex311.htm EX-31.1 11705
10 EX-31.2 d63231dex312.htm EX-31.2 11691
11 EX-32.1 d63231dex321.htm EX-32.1 4593
12 EX-32.2 d63231dex322.htm EX-32.2 4568
18 GRAPHIC g63231g01c01.jpg GRAPHIC 87999
19 GRAPHIC g63231g01g78.jpg GRAPHIC 106991
20 GRAPHIC g63231g13b01.jpg GRAPHIC 66753
21 GRAPHIC g63231g99y95.jpg GRAPHIC 65069
  Complete submission text file 0001193125-21-054629.txt   10672998

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA gbt-20201231.xsd EX-101.SCH 56830
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20201231_cal.xml EX-101.CAL 58367
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20201231_def.xml EX-101.DEF 254967
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20201231_lab.xml EX-101.LAB 520889
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20201231_pre.xml EX-101.PRE 438943
22 EXTRACTED XBRL INSTANCE DOCUMENT d63231d10k_htm.xml XML 1438075
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37539 | Film No.: 21673208
SIC: 2834 Pharmaceutical Preparations